BiotechTube
Home/Nanexa AB/Anders Johansson
AJ

Anders Johansson

Head of Intellectual Property, Co-founder

Nanexa AB

Therapeutic Areas

OncologyMetabolic Disease

Nanexa AB Pipeline

DrugIndicationPhase
NEX-20Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)Phase I
NEX-18Oncology (Multiple Myeloma)Preclinical
NEX-22Type 2 Diabetes / ObesityDiscovery/Preclinical

Leadership Team at Nanexa AB

DW
David Westberg
Chief Executive Officer (CEO)
CD
Cecilia Danckwardt-Lillieström
Chief Financial Officer (CFO)
MR
Mårten Rooth
Chief Technology Officer (CTO), Co-founder
JH
Joel Hellrup
Head of Pharmaceutical R&D
KB
Kristine Bäck
Director Project Management
GA
Göran Ando
Chairman of the Board
BS
Birgit Stattin Norinder
Board Member
RD
Richard Davis
Board Member
JD
Jakob Dynnes Hansen
Board Member
View full Nanexa AB profile